{"id":219569,"date":"2024-09-27T00:00:00","date_gmt":"2024-09-27T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041110-medtech-heart-valve-devices-market-insights-asia\/"},"modified":"2026-05-16T23:05:50","modified_gmt":"2026-05-16T23:05:50","slug":"47042069-medtech-heart-valve-devices-market-insights-asia-pacific","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042069-medtech-heart-valve-devices-market-insights-asia-pacific\/","title":{"rendered":"Heart Valve Devices – Market Insights – Asia Pacific"},"content":{"rendered":"

The Asia Pacific heart valve device market will continue to experience rapid growth<\/span>, largely driven by the adoption of THV<\/abbr> devices. Positive clinical outcomes supporting THV<\/abbr> devices and the emergence of novel products will expand the existing patient population, driving continued growth in the heart valve device market.<\/p>\n

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for heart valve devices in the Asia Pacific region from 2019 through 2033.<\/p>\n

Recent market developments and events have a significant impact on the heart valve device market.<\/strong><\/p>\n

What will be the impact of the recent mergers and acquisitions on the Asia Pacific heart valve device market?<\/p>\n

What technologies are larger players adding to their product portfolios through acquisitions?<\/p>\n

How does the cost-sensitive nature of Asia Pacific countries affect the heart valve device market?<\/p>\n

The Asia Pacific heart valve replacement device market will be driven by rapid adoption of TAVI<\/abbr><\/strong>.<\/b><\/p>\n

Which new TAVI<\/abbr>\u00a0devices are poised to enter the market? What impact will these newer devices have on market dynamics and market growth?<\/p>\n

How does different factors influence the adoption of TAVI<\/abbr> devices across the geography?<\/p>\n

How does the presence of domestic players impact the TAVI<\/abbr> market?<\/p>\n

The market landscape is evolving for surgical heart valve replacement and surgical annuloplasty repair devices.<\/strong><\/p>\n

How will new THV<\/abbr> device technologies affect the surgical repair and replacement device markets?<\/p>\n

How significantly does the high cost of TMVR<\/abbr> impact the adoption of TMVR<\/abbr> devices in the Asia Pacific region?<\/p>\n

When is TMVI<\/abbr> therapy expected to enter the Asia Pacific market? What TMVI<\/abbr> devices are in development?<\/p>\n

The competitive landscape for the THV<\/abbr> device market is evolving. <\/strong><\/p>\n

Which competitors have the most diverse portfolios in the heart valve device space?<\/p>\n

How does the presence of local competitors differ by country?<\/p>\n

How companies gain a competitive edge through mergers and acquisitions?<\/p>\n

What market dynamics will occur between TMVI<\/abbr> and TMVR<\/abbr> devices once TMVI<\/abbr> is approved in the Asia Pacific market?<\/p>\n

Securing approval for additional indications is a key strategy in the THV<\/abbr> device market. <\/strong><\/p>\n

What clinical trials are currently taking place that could expand the scope of eligible patient population for TAVI<\/abbr>?<\/p>\n

Which THV<\/abbr> device segments are being driven by the approval of additional indications?<\/p>\n

Clinical trial results play an important factor in the heart valve device market.<\/strong><\/p>\n

How are clinical studies and guidelines impacting the uptake of THV<\/abbr>\u00a0devices?<\/p>\n

What segments have been the most impacted by clinical results?<\/p>\n

What will be the market impact of the approval of expanded indications for TAVI<\/abbr>?<\/p>\n

What technologies are larger players focusing on and how will the first-mover advantage benefit these competitors?<\/p>\n","protected":false},"template":"","class_list":["post-219569","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-heart-valve-devices","medtech-geography-asia-pacific","medtech-date-983"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/219569","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/219569\/revisions"}],"predecessor-version":[{"id":305730,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/219569\/revisions\/305730"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=219569"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}